Novo Nordisk’s GLP-1 agonist Ozempic has shown efficacy in yet another indication, achieving a 24% reduction in kidney disease-related events in people with type 2 diabetes and chronic kidney disease ...

Lower-income adults with an aging parent, spouse or partner are more likely to be caregivers than those in higher income tiers. Fresh data delivered Saturday mornings Thank you for subscribing! People ...